Available via license: CC BY-NC 4.0
Content may be subject to copyright.
CORRECTION
Correction to: Cost Analysis of FreeStyle Libre
Ò
2
System in Type 2 Diabetes Mellitus Population
Itziar Oyagu
¨ez .Fernando Go
´mez-Peralta .Sara Artola .
Francisco J. Carrasco .Juana Carretero-Go
´mez .Javier Garcı
´a-Soidan .
Ricardo Go
´mez-Huelgas .Juan F. Merino-Torres .Antonio Pe
´rez
ÓThe Author(s) 2021
Correction to: Diabetes Ther
https://doi.org/10.1007/s13300-021-01064-4
In original article, there are few facts published
incorrectly. The correct Table 4is given below.
There are few corrections in the second
paragraph under the Table 4.
‘‘In the additional scenario considering sev-
ere and non-severe hypoglycaemic episodes, the
total annual cost reached €2,951,884 and
€2,309,089 for the cohort with SMBG and the
FreeStyle Libre 2 system, respectively.’’
‘‘Cost savings with the use of the FreeStyle
Libre 2 system as compared to SMBG would be
up to €642,795 per year (-21.8%) (Table 4).’’
The original article has been updated.
The original article can be found online at https://doi.
org/10.1007/s13300-021-01064-4.
I. Oyagu
¨ez (&)
Pharmacoeconomics and Outcomes Research Iberia
(PORIB), Paseo Joaquı
´n Rodrigo 4 - letra I, Pozuelo
de Alarco
´n, 28224 Madrid, Spain
e-mail: ioyaguez@porib.com
F. Go
´mez-Peralta
Unidad de Endocrinologı
´a y Nutricio
´n, Hospital
General de Segovia, Segovia, Spain
S. Artola
Centro de Salud Jose
´Marva
´, Madrid, Spain
F. J. Carrasco
UGC Medicina Interna, Hospital Universitario Juan
Ramo
´n Jime
´nez, Huelva, Spain
J. Carretero-Go
´mez
Servicio de Medicina Interna, Hospital de Zafra,
Badajoz, Spain
J. Garcı
´a-Soidan
Porrin
˜o Primary Care Centre, Pontevedra, Spain
R. Go
´mez-Huelgas
Servicio de Medicina Interna, Hospital Regional
Universitario de Ma
´laga, Instituto de Investigacio
´n
Biome
´dica de Ma
´laga (IBIMA), Universidad de
Ma
´laga; and Ciber Fisiopatologı
´a de la Obesidad y la
Nutricio
´n (CIBEROBN), Instituto de Salud Carlos III,
Madrid, Spain
J. F. Merino-Torres
Endocrinologı
´a y Nutricio
´n, Departamento
Medicina, Hospital Universitario y Polite
´cnico La Fe,
Universitat de Vale
`ncia, Valencia, Spain
A. Pe
´rez
Servicio de Endocrinologı
´a y Nutricio
´n. Hospital de
la Santa Creu i Sant Pau, IIB-Sant Pau, CIBERDEM,
Universitat Auto
`noma de Barcelona, Barcelona,
Spain
Diabetes Ther
https://doi.org/10.1007/s13300-021-01093-z
Open Access. This article is licensed under a
Creative Commons Attribution-NonCommer-
cial 4.0 International License, which permits
any non-commercial use, sharing, adaptation,
distribution and reproduction in any medium
or format, as long as you give appropriate credit
to the original author(s) and the source, provide
a link to the Creative Commons licence, and
indicate if changes were made. The images or
other third party material in this article are
included in the article’s Creative Commons
licence, unless indicated otherwise in a credit
line to the material. If material is not included
in the article’s Creative Commons licence and
your intended use is not permitted by statutory
regulation or exceeds the permitted use, you
will need to obtain permission directly from the
copyright holder. To view a copy of this licence,
visit http://creativecommons.org/licenses/by-
nc/4.0/.
Table 4 Results of the sensitivity analyses
Total annual cost per 1000 T2DM patients
SMBG FreeStyle
Libre 2
system
Absolute difference FreeStyle Libre 2
system vs SMBG (percentage variation)
Base case for T2DM with basal-bolus insulin €2,700,499 €2,119,546 €-580,953 (-21.5%)
SA1 (1.3 severe hypoglycaemic episodes/patient-
year) [37]
€1,793,470 €1,655,147 €-138,323 (-7.7%)
SA2 (3 strips & lancets a day for SMBG) €2,295,071 €2,119,546 €-175,525 (-7.6%)
SA3 (0.66 strips & lancets a day for FreeStyle
Libre 2 users) [38]
€2,700,499 €2,181,712 €-518,787 (-19.2%)
SA4 (3 strips & lancets a day for SMBG, and 0.66
for FreeStyle Libre 2 users)
€2,295,071 €2,181,712 €-113,360 (-4.9%)
SA5 (13 strips & lancets a day for SBMG,
equivalent to daily scans in real-world studies)
[38]
€3,646,496 €2,119,546 €-1,526,950 (-41.9%)
SA6 (including severe and non-severe
hypoglycaemic episodes)
€2,951,884 €2,309,089 €-642,795 (-21.8%)
SA sensitivity analysis, SMBG self-monitoring of capillary blood glucose, T2DM type 2 diabetes mellitus
Diabetes Ther
